Zollinger–Ellison Syndrome
Videos
Overview
Zollinger–Ellison syndrome (ZES) is a rare disorder in which tumors called gastrinomas produce excessive amounts of gastrin, a hormone that stimulates acid production. This leads to extremely high acid levels, causing severe peptic ulcer disease, abdominal pain, reflux, and chronic diarrhea. Gastrinomas may occur in the pancreas or duodenum and can be associated with genetic conditions such as MEN1. Early diagnosis is essential to prevent complications.
Causes
ZES is caused by gastrin-secreting tumors, most commonly located in the pancreas or duodenum. These tumors may be sporadic or associated with multiple endocrine neoplasia type 1 (MEN1). Excess gastrin leads to uncontrolled acid production and severe mucosal injury.
Risk Factors
Risk factors include a personal or family history of MEN1, endocrine tumors, chronic ulcer disease, and unexplained severe or recurrent peptic ulcers. ZES is rare but should be suspected in patients with refractory ulcer disease.
How Zollinger–Ellison Syndrome Affects the Body
Excess acid damages the stomach and duodenum, causing severe ulcers, inflammation, pain, and diarrhea. High acid levels may impair digestion, cause malabsorption, and lead to complications such as bleeding or perforation.
Complications
Complications include severe peptic ulcer disease, bleeding, perforation, gastric outlet obstruction, chronic diarrhea, weight loss, and potential spread of gastrinomas. Long-standing acid exposure increases the risk of esophagitis and Barrett's esophagus.
Symptoms and Signs
Symptoms include severe abdominal pain, recurrent ulcers, chronic diarrhea, reflux, nausea, vomiting, weight loss, and symptoms that do not improve with standard acid suppression therapy.
Diagnosis
Diagnosis may include fasting gastrin levels, secretin stimulation testing, endoscopy, CT scan, MRI, endoscopic ultrasound, and evaluation for MEN1. Imaging helps locate gastrinomas and assess disease severity.
Differential Diagnosis
Conditions that mimic ZES include peptic ulcer disease, GERD, bile reflux, gastritis, functional dyspepsia, and other causes of chronic diarrhea.
Lifestyle Modifications
Lifestyle strategies include avoiding NSAIDs, reducing alcohol and smoking, eating smaller meals, and avoiding foods that worsen acid production. These strategies help reduce symptoms but do not treat the underlying tumor.
Treatment Options
Treatment includes high-dose acid suppression therapy, management of ulcers, and surgical removal of gastrinomas when possible. Patients with MEN1 may require specialized endocrine evaluation. Advanced cases may require targeted therapy or oncology consultation.
When to See a Doctor
Seek evaluation if you experience severe or recurrent ulcers, chronic diarrhea, or symptoms that do not improve with standard GERD or ulcer therapy.
When to Seek Treatment
Treatment is recommended when symptoms interfere with eating, hydration, or daily life, or when testing confirms elevated gastrin levels or gastrinomas.
Long-Term Outlook
Long-term outcomes depend on tumor behavior and acid control. Ongoing follow-up is essential to monitor gastrin levels, manage ulcers, and evaluate for MEN1.
Prognosis
With proper treatment, many patients experience significant symptom improvement. Prognosis depends on tumor location, size, and whether gastrinomas are localized or metastatic.
Why Choose Dr. de la Cruz-Muñoz
Dr. Nestor de la Cruz-Muñoz provides expert evaluation and management of Zollinger–Ellison syndrome, offering advanced diagnostic testing and coordinated care for complex foregut and endocrine-related disorders.
